Center for Clinical & Translational Science
The University of Utah Center for Clinical and Translational Science (CCTS) serves as an academic home for clinical and translational research, developing innovative health services for the community and researchers, and training a new generation of clinical and translational investigators.
Eight Core Areas
The CCTS is composed of eight different core areas:
CCTS/PPH Launches Interdisciplinary Seed Grant Initiative
Call For Proposals with Personalized Health, Translational Research Focus
Clinical and Translational Science (CCTS) (http://medicine.utah.edu/ccts/) and the Program in Personalized Health announce a request for proposals for pilot projects describing innovative approaches to personalized health and/or translational research. The goal of this funding announcement is to encourage interdisciplinary, collaborative study designs that engage multiple departments and/or colleges within the University and its affiliated institutions including the Veterans Affairs Medical Center, Intermountain Healthcare, and the Utah Department of Health.
Grant proposals are due May 29th, 2015 at 5:00 pm. Please see the University of Utah's CompetitionSpace website https://utah.infoready4.com/ for proposal submission and additional information. Questions about this funding opportunity can be directed to Emily Coonrod, Manager, Program in Personalized Health at email@example.com or 801-585-2268.
It is with sadness that we announce that Dr. Don McClain will be leaving his position as co-director of our Center for Clinical and Translational Science (CCTS) to direct a new Center on Diabetes, Obesity and Metabolism at Wake Forest Baptist Medical Center.
All of the Core Directors, CCTS staff and investigators will greatly miss Dr. McClain. He and CCTS co-director Dr. Carrie Byington established a unified Study Design and Biostatistics Core that served as the impetus for the new Department of Population Health Sciences in the School of Medicine, launched educational programs such as the Master of Clinical Investigation and propelled a fourfold increase in our translational research funding to $72.6 million.
Dr. Carrie Byington, a member of the national CTSA Executive Committee and leaders in scientific workforce development will assume the role of Director. Dr. Will Dere, who recently joined us executive director of our Program in Personalized Health, has agreed to join Dr. Byington as co-director of the CCTS. We are fortunate to have someone of Dr. Dere’s experience to step in as the new co-director. He is an internationally regarded medical researcher with 25 years’ experience in the pharmaceutical industry, and his expertise in drug discovery will greatly benefit the CCTS mission of bringing promising bench science to patient care.